Live tape
Top 8, mentions 7d17,656MSFT3,331 mentions▲ +0.08GOOGL2,705 mentions▲ +0.05AAPL2,320 mentions▲ +0.07META2,240 mentions▲ +0.04SPCX1,997 mentions▲ +0.06SNDK1,870 mentions▲ +0.06NVDA1,761 mentions▲ +0.07QQQ1,432 mentions▲ +0.04

Equity · Healthcare

TXG

10x Genomics, Inc. · NasdaqGS

$47.00 +2.35% 1D Finazon · prior-day close · Jul 28, 2026

Reddit mentioned TXG 7 times in the 30 days to 15 July 2026, across 3 of the communities we track. All of them were scored for sentiment: 71% read bullish, 0% bearish and 29% neither. Reddit data updated 15 July 2026.

Price · Chart Chart by TradingView

The chart above plots the price of TXG over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 63 sessions over that window: $22.44 on 1 May 2026 through $47.00 on 28 July 2026. Finazon · prior-day close.

Market cap $6.0B
52-week range $11.34 – $48.06
Avg volume 653.8K
Mentions · 30d 7
Net sentiment +0.07

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

The Distributed Sentinel 15 Jul 2026

The crowd leans clearly bullish on TXG

This is a social signal to weigh against price and insider flow, not to trade on alone.

Crowd sentiment on TXG · 30d

n = 7 scored · Method
+0.07
Neutral
Bullish 71%
Neither 29%
Bearish 0%

TXG · crowd attention × price

Share ↗
7 mentions
Bar chart of daily Reddit mentions for TXG over the last 30 days, read against the left-hand axis; days with zero mentions show no bar. A solid accent line overlays the daily closing price on its own right-hand scale. A dashed lead-in marks the untracked days before tracking began.035$48.06$49$37.43$371 Jul8 Jul15 Jul22 Jul30 Jul

Reddit mentions per day — left axis Busiest day in the window Daily closing price, USD — right axis Before tracking began — not zero

The chart plots daily Reddit mentions of TXG over the 30 days to 15 July 2026: 7 in total, busiest on 15 July with 4, and 4 on the last day counted. The line is the daily close over the same window: $39.00 on 1 July, $47.00 on 28 July.

Finazon · prior-day close

Where TXG is discussed

Share of tracked-subreddit mentions · 30d
r/wallstreetbets 57% 4 mentions +0.07
r/stocks 29% 2 mentions +0.10
r/investing 14% 1 mention −0.02

TXG insider trades

SEC Form 4 · last 90 days · newest reported trade 22 Jun 2026
Open-market buys 0
Open-market sells 6
Net sold $2.58M
Non-trade filings 6
Date Insider Type Shares Value
22 Jun 2026 Saxonov Serge Chief Executive Officer Sell 30,000 $1.03M
16 Jun 2026 SULIMAN SHEHNAAZ Director Sell 5,723 $187K
26 May 2026 Saxonov Serge Chief Executive Officer Sell 10,718 $265K
22 May 2026 Taich Adam Chief Financial Officer Sell 15,098 $369K
22 May 2026 Hindson Benjamin J. See Remarks Sell 11,595 $283K
22 May 2026 Saxonov Serge Chief Executive Officer Sell 18,175 $444K
Compensation mechanics (6 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
04 Jun 2026 Kosaraju Sridhar Director Award 8,829
04 Jun 2026 MATEO ALAN Director Award 8,829
04 Jun 2026 Popovits Kimberly J Director Award 8,829
04 Jun 2026 STUELPNAGEL JOHN R Director Award 8,829
04 Jun 2026 SULIMAN SHEHNAAZ Director Award 8,829
04 Jun 2026 Teichmann Sarah A. Director Award 8,829

TXG reported financials

SEC EDGAR XBRL

TXG reported revenue of $642.8M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$43.5M.

Figure Reported Period
Revenue $642.8M 31 Dec 2025 fiscal year
Net income −$43.5M 31 Dec 2025 fiscal year
Diluted EPS −$0.35 31 Dec 2025 fiscal year
Total assets $1.0B 31 Mar 2026 at period end
Total equity $814.3M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

TXG earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.10
31 Dec 2025 FY 2025 $-0.35
30 Sep 2025 Q3 2025 $-0.22
30 Jun 2025 Q2 2025 $0.28

Reported figures & scheduled dates · SEC EDGAR filings

TXG institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a TXG position for the quarter ended 31 Mar 2026 — a combined $423.2M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
ARK Investment Management Held (±25%) −7.5% shares 11,717,317 $248.8M
AQR Capital Management Held (±25%) −1.6% shares 2,538,256 $53.7M
Millennium Management Added +66.5% shares 2,068,414 $43.9M
Renaissance Technologies Trimmed −34.9% shares 1,008,739 $21.4M
Balyasny Asset Management New position 989,522 $21.0M
Citadel Advisors Added +468.5% shares 743,734 $15.8M
Two Sigma Investments Trimmed −65.2% shares 402,427 $8.5M
Man Group Trimmed −31.5% shares 269,264 $5.7M
Marshall Wace Held (±25%) +11.5% shares 102,272 $2.2M
D. E. Shaw & Co. Trimmed −60.7% shares 68,557 $1.5M

Source: SEC EDGAR 13F filings

TXG fails-to-deliver

SEC CNS data

On 30 Jun 2026, 29,751 shares of TXG failed to deliver (about $1.1M).

Settlement date Shares failed Notional
30 Jun 2026 29,751 $1.1M
24 Jun 2026 72 $2K
22 Jun 2026 2,282 $79K

Source: SEC fails-to-deliver (CNS) data

TXG — frequently asked questions

From live data

Is Reddit bullish or bearish on TXG?

Across 7 classified TXG mentions in the last 30 days, 71% read bullish, 0% bearish and 29% neutral. Crowd sentiment is a social signal, not investment advice.

When did TXG last report earnings?

10x Genomics (TXG) last reported earnings on 31 Mar 2026 for Q1 2026, per SEC filings.

Are TXG insiders buying or selling?

SEC Form 4 filings over the last 90 days show 0 buys and 6 sells by TXG insiders on the open market. A further 6 filings were grants, awards, gifts or exercises rather than open-market trades.

What exchange is TXG listed on?

10x Genomics trades on NASDAQ under the ticker TXG.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.